ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/007/SRR5985167/SRR5985167.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/006/SRR5985166/SRR5985166.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/004/SRR5985164/SRR5985164.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/008/SRR5985168/SRR5985168.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/003/SRR5985163/SRR5985163.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR598/005/SRR5985165/SRR5985165.fastq.gzprimaryOK200GenomicsRadiation Oncology, Osaka University Graduate School of Medicinehttps://www.ebi.ac.uk/ena/browser/view/PRJNA400459Homo sapiensxref:PubMed:30455990ChIP-seq analysis of HeLa cancer stem cells and non-cancer stem cells regarding Pol II, H3K4me3 and H3K27Ac. Overall design: Epigenetic difference between HeLa nonCSC and CSCs.ENAfalseHomo sapiensChIP-seq analysis of HeLa cancer stem cells and non-cancer stem cells using Pol II, H3K4me3 and H3K27Ac.2025-09-242018-12-03PRJNA400459GSE103187960630455990